Anavar vs Primobolan for Cutting: Pharmacology, Evidence, Side Effects, and Which One Fits Your Protocol

The Anavar vs Primobolan comparison is one of the most common questions in steroid research, and one of the most poorly answered. Both compounds are DHT derivatives. Both are non-aromatising. Both are considered “mild.” But they differ fundamentally in route of administration, anabolic potency, hepatotoxicity, cost, lipid impact, evidence base, and the specific role each one plays in a cutting protocol. No competitor article covers these differences with pharmacological precision because doing so requires understanding the structural chemistry, the binding affinity data, and the clinical evidence gap between the two compounds. This article provides that comparison in full. At Hemi Pharma UK, we believe that choosing between two compounds should be based on their pharmacological profiles, not on forum consensus or brand reputation.

The single most important difference between Anavar and Primobolan is not their anabolic rating or their side effect profile. It is the quality of evidence behind each one. Oxandrolone has been studied in dozens of randomised controlled trials across multiple clinical populations, with body composition changes measured by DEXA and MRI, protein synthesis rates quantified by stable isotope infusion, and strength changes tracked week by week. Methenolone has almost no modern clinical trial data. Its pharmacological profile is well characterised, but its clinical outcomes are largely extrapolated from its chemical structure and from anecdotal bodybuilding experience. This evidence asymmetry should inform every claim made about the two compounds.

How Do the Anabolic and Androgenic Profiles of Anavar and Primobolan Actually Compare?

The anabolic-to-androgenic ratio of each compound, measured in rat bioassays relative to testosterone (100:100), provides the starting framework. Oxandrolone has a ratio of approximately 322:24. Methenolone has a ratio of approximately 88:44 to 57. These numbers require interpretation rather than face-value acceptance.

Oxandrolone’s high anabolic rating (322) reflects its potent nitrogen retention and protein synthesis effects. Its very low androgenic rating (24) reflects minimal activity at androgen-sensitive tissues such as the prostate and skin. In practical terms, this means Anavar produces substantial muscle-preserving and strength-enhancing effects relative to its androgenic side effects (acne, hair loss, prostate stimulation).

Methenolone’s moderate anabolic rating (88) and low androgenic rating (44 to 57) indicate a compound that is anabolically weaker than testosterone and substantially weaker than oxandrolone on a milligram-for-milligram basis. However, Primobolan is typically dosed at 400mg to 800mg per week (injectable enanthate), while Anavar is dosed at 30mg to 60mg daily (210mg to 420mg per week total). At these real-world doses, the total anabolic stimulus from a Primobolan cycle approaches or exceeds that of a moderate Anavar cycle, despite the lower per-milligram potency. The comparison is therefore dose-dependent, not simply ratio-dependent.

The Kicman (2008) review in the British Journal of Pharmacology noted that the rat bioassay ratios have significant limitations when extrapolated to human clinical outcomes, because the assays measure effects on specific tissues (levator ani muscle for anabolic, ventral prostate for androgenic) that do not perfectly translate to whole-body human physiology (Kicman, 2008). The ratios are useful for relative comparison but should not be treated as precise predictive values.

Why Is the Route of Administration the Most Consequential Difference Between Anavar and Primobolan?

Oxandrolone is an oral steroid with a 17-alpha-alkyl modification that protects it from first-pass hepatic metabolism. This modification is what gives Anavar its high oral bioavailability (97%), its predictable dosing, and its convenience. It is also what produces its most significant side effects: hepatic lipase upregulation (causing the HDL crash described in our Anavar and cholesterol article) and hepatic stress (mild transaminase elevation in most users).

Methenolone enanthate (Primobolan Depot) is an injectable steroid that bypasses first-pass hepatic metabolism entirely. It is not 17-alpha-alkylated. The oral form (methenolone acetate) uses a different structural modification (1-methylation plus an acetate ester) that provides some oral bioavailability without the 17-alpha-alkylation. This is a critical distinction: Primobolan, in both its injectable and oral forms, does not produce the hepatic lipase activation that drives oral steroid lipid damage.

The practical consequences of this difference are substantial. Injectable Primobolan produces significantly less HDL suppression than oral Anavar at equivalent anabolic doses. It produces no meaningful liver enzyme elevation. It avoids the cardiovascular risk profile that accompanies the lipid derangement of 17-alpha-alkylated orals. For users whose primary concern is cardiovascular and hepatic safety during a cutting cycle, Primobolan’s injectable route offers a genuine advantage over oral Anavar.

The tradeoff is that injectable administration requires intramuscular injection, typically twice per week for the enanthate ester (which has a half-life of approximately 5 days). Users who prefer oral-only protocols, or who are unwilling or unable to self-inject, are limited to Anavar or the less commonly available oral Primobolan acetate.

Which Compound Has Better Clinical Evidence for Muscle Preservation During a Caloric Deficit?

This is where the comparison becomes asymmetric. Oxandrolone has been studied in multiple randomised controlled trials involving caloric restriction or catabolic states, with body composition outcomes measured by DEXA and MRI. The data from these trials (increased lean body mass, reduced fat mass, improved nitrogen balance, enhanced protein synthesis efficiency) provides a robust evidence base for Anavar’s anti-catabolic properties during a deficit.

Methenolone has virtually no equivalent clinical trial data. Its reputation for muscle preservation is based on its pharmacological profile (DHT derivative, non-aromatising, moderate AR binding affinity) and on decades of bodybuilding experience. The Saartok et al. (1984) study in Endocrinology characterised methenolone’s binding affinity to the androgen receptor in skeletal muscle, finding it binds with moderate affinity relative to methyltrienolone (Saartok et al., 1984). This confirms that methenolone can activate the AR in muscle tissue, but it does not quantify the magnitude of the anti-catabolic effect in a deficit.

The honest assessment is this: Anavar’s clinical evidence for muscle preservation during cutting is strong. Primobolan’s is pharmacologically plausible but clinically unproven. This does not mean Primobolan is ineffective. It means that when someone claims “Primobolan preserves more muscle than Anavar during a cut,” they are making a statement that has no controlled trial support. The bodybuilding community’s consensus on Primobolan may well be correct, but it remains anecdotal rather than evidence-based.

How Does the Side Effect Profile Differ Between Anavar and Primobolan in Practice?

Lipid impact

Anavar produces severe HDL suppression (50% or greater) through hepatic lipase upregulation, as detailed in our dedicated article. Primobolan Depot, as an injectable non-alkylated steroid, produces substantially less lipid disruption. HDL may decrease modestly (10 to 20%, comparable to injectable testosterone), but the dramatic HDL crash characteristic of oral steroids does not occur. This is Primobolan’s most significant safety advantage over Anavar.

Liver toxicity

Anavar produces mild transaminase elevation in approximately 40% of users, which is generally reversible and clinically insignificant at moderate doses. Primobolan produces no meaningful hepatotoxicity in either its injectable or oral form. The 1-methyl modification of methenolone does not produce the same hepatic stress as 17-alpha-alkylation.

Hair loss

Both compounds are DHT derivatives, and both carry androgenic activity at the hair follicle. However, methenolone’s androgenic rating (44 to 57) is higher than oxandrolone’s (24), suggesting marginally greater hair loss risk per unit of anabolic effect. At real-world doses (Primobolan at 400 to 800mg/week vs Anavar at 30 to 60mg/day), the total androgenic load at the follicle may be comparable. As covered in our Anavar hair loss article, finasteride cannot protect against either compound because both are already 5-alpha-reduced (or in Primobolan’s case, already a DHT derivative that does not undergo further 5-alpha reduction to a more potent metabolite).

SHBG suppression

Anavar suppresses SHBG dramatically, often to single-digit nmol/L values. This amplifies the bioavailable fraction of co-administered testosterone and creates the oestrogen paradox described in our dedicated article. Primobolan has very low SHBG binding affinity (approximately 16% of testosterone’s affinity, and oxandrolone has essentially zero SHBG binding). Injectable Primobolan suppresses SHBG to a lesser degree than oral Anavar because it bypasses first-pass hepatic metabolism, which is one of the mechanisms through which oral steroids suppress SHBG production. This means Primobolan has less impact on the free testosterone and free oestradiol fractions, producing a more stable hormonal environment.

HPTA suppression

Both compounds suppress the HPT axis when used at bodybuilding doses. Neither should be run without a testosterone base in males. PCT requirements are similar, adjusted for the longer clearance time of Primobolan Depot (the enanthate ester requires 2 to 3 weeks to clear before PCT initiation, similar to testosterone enanthate).

What Does Each Compound Cost and Is Primobolan Worth the Premium?

Primobolan is consistently the most expensive commonly used anabolic steroid. A typical 8-week cutting cycle of Primobolan Depot at 400mg per week requires 3,200mg total. Anavar at 40mg per day for 8 weeks requires 2,240mg total. Per milligram, Primobolan typically costs 3 to 5 times more than pharmaceutical-grade oxandrolone, and the total cycle cost reflects this premium.

The cost differential is also the primary reason Primobolan is one of the most frequently counterfeited steroids. Users purchasing “Primobolan” from unverified sources may receive methenolone underdosed, substituted with cheaper compounds (often nandrolone or boldenone), or containing no methenolone at all. This is one of the practical reasons that Anavar, when sourced from a manufacturer with independent analytical verification (such as Janoshik-tested Hemi Pharma products), offers a more reliable cost-to-benefit ratio: you can verify exactly what you are getting.

When Should You Choose Anavar and When Should You Choose Primobolan?

The decision framework is clearer than most comparison articles suggest, because the two compounds serve overlapping but not identical roles:

Choose Anavar when: you prefer oral administration; you want the strongest evidence-backed anti-catabolic effect during a deficit; you value the SHBG-mediated amplification of your testosterone base; your cycle is 6 to 8 weeks and you will monitor lipids; cost is a factor; you want the creatine phosphate resynthesis strength enhancement (as covered in our Anavar and creatine article).

Choose Primobolan when: you can self-inject and prefer the injectable route; cardiovascular and hepatic safety is your primary concern; you want to run a longer cycle (10 to 16 weeks) without the lipid damage that extended oral use produces; you are willing to pay the premium and can verify product authenticity; you want minimal hormonal disruption (less SHBG suppression, less oestrogen amplification).

For many users, the optimal approach is not Anavar vs Primobolan but Anavar and Primobolan sequentially. Running Primobolan as the base injectable throughout a 12-week cut and adding Anavar for the final 6 weeks captures the lipid-friendly profile of injectable Primobolan for the majority of the cycle while using Anavar’s more potent anti-catabolic effect during the hardest phase of the deficit. This approach limits oral steroid exposure to 6 weeks while maintaining anabolic coverage for the full 12.

Frequently Asked Questions

Is Primobolan safer than Anavar?

For cardiovascular and hepatic health, injectable Primobolan is safer than oral Anavar. The absence of 17-alpha-alkylation means Primobolan does not produce the hepatic lipase activation or liver stress that Anavar does. However, “safer” depends on the specific risk being measured. Both suppress the HPT axis. Both carry androgenic effects. Both require PCT. Primobolan’s safety advantage is specific to the lipid and liver compartments, which are the areas where oral steroids produce their most clinically significant short-term harm.

Does Primobolan preserve more muscle than Anavar during a cut?

There is no controlled trial comparing the two directly. Anavar has DEXA and MRI-confirmed data showing lean mass preservation and fat loss during catabolic states. Primobolan’s muscle-preserving reputation is based on pharmacological plausibility and bodybuilding consensus, not clinical trial outcomes. At equivalent real-world doses, both likely preserve muscle effectively during moderate caloric restriction, but the evidence base favours Anavar.

Can I stack Anavar and Primobolan together?

Yes. The combination is pharmacologically rational: Anavar provides the oral anti-catabolic boost and strength enhancement, while Primobolan provides the injectable anabolic base without the lipid damage of a second oral. Running both with a testosterone base (such as testosterone cypionate at TRT doses) is a common advanced cutting protocol. Limit Anavar to 6 weeks within the longer Primobolan cycle to manage lipid exposure.

Why is Primobolan so expensive compared to Anavar?

The cost reflects both the raw material expense and the dosing requirements. Methenolone is more expensive to synthesise than oxandrolone. Additionally, Primobolan requires 400 to 800mg per week (2,800 to 5,600mg per cycle at 7 weeks) compared to Anavar’s 210 to 420mg per week total. The higher per-milligram cost multiplied by the higher total milligram requirement produces a cycle cost that is typically 3 to 5 times greater. This premium is the primary reason Primobolan is heavily counterfeited and why product verification is especially important.

Which compound causes less hair loss: Anavar or Primobolan?

Anavar has a lower androgenic rating (24 vs 44 to 57), suggesting less androgenic activity at the hair follicle per milligram. However, at real-world doses, the total androgenic load from each cycle may be comparable. Both are DHT derivatives, and finasteride cannot protect against either. For genetically predisposed individuals, neither compound is hair-safe, but Anavar’s lower androgenic profile gives it a marginal advantage in this specific comparison.